January 26, 2025 - 09:19

Vivident, an innovative company focused on developing artificial intelligence-driven character intellectual property technology, has successfully raised $1.5 million in seed funding. This impressive round of investment attracted global investors from regions including South Korea, Japan, the United States, and Hong Kong.
The funding was backed by prominent venture capital firms, showcasing strong interest in Vivident's vision and technological advancements. Notable participants in this funding round included Hashed, Mashup Ventures, TheVentures, Modhaus, Sfermion, CVC Z Venture Capital, Decima Fund, and CMCC Global's Titan Fund.
With this financial boost, Vivident aims to advance its AI character technology, which has the potential to revolutionize the way characters are created and utilized across various media platforms. The company is poised to make significant strides in the entertainment and gaming industries, where the demand for unique and engaging character IP continues to grow. This funding marks a crucial step in Vivident's journey toward becoming a leader in the AI character space.
June 28, 2026 - 08:54
Innovation Lab Roadshow Brings Adaptive Activities and Assistive Technology to Snohomish County I/DD CommunityA traveling showcase of adaptive tools and hands-on activities is making its way through Snohomish County, bringing new opportunities for people with intellectual and developmental disabilities....
June 27, 2026 - 21:55
World's first 100% electric hydrofoil pilot boat hits the waterArtemis Technologies has unveiled its newest electric hydrofoil vessel, the EF-12, calling it the world`s first completely electric and zero-emissions pilot boat. Designed specifically for...
June 27, 2026 - 00:43
UCF abruptly shuts down some campus libraries and technology resourcesThe University of Central Florida has suddenly shut down several campus libraries and technology resource centers, leaving students and staff scrambling for alternatives. The closures took effect...
June 26, 2026 - 00:10
Partnership with Oxford Nanopore Technologies will support development of RNA liquid biopsy for cancer early detectionA new partnership between a diagnostics company and Oxford Nanopore Technologies is set to push forward the development of a blood test that can spot cancer at its earliest stages. The...